Brainshuttle™ Launched in Hawaii! Novel Alzheimer’s Drug Trontinemab with Brainshuttle™ Technology A new Alzheimer’s clinical study using the investigational drug trontinemab, engineered with Brainshuttle™ technology, is now accepting participants in Hawaii. This approach aims to achieve rapid amyloid clearance with…
- Call or text: +1 (808) 261-4476
- Mon-Fri (8:00am - 5:00pm) Lunch Break 12:30pm-1:30pm
- info@hawaiineuroscience.com
Edit Content